Heat Biologics Inc (HTBX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.38 +0.01 (+0.42%) 05/02/22 [NYSE Arca]
N/A x N/A N/A x N/A
Post-market 2.38 unch (unch) -
for Mon, May 2nd, 2022
Results
download Want to compare other data? Select Fields| Symbol | HTBX | CRBP | NTRB | ||
| Company | Heat Biologics Inc | Corbus Pharmaceuticals Hldgs Inc | Nutriband Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 2.41 | 8.15 | 5.33 | ||
| High | 2.48 | 8.26 | 6.66 | ||
| Low | 2.33 | 7.11 | 5.33 | ||
| Last | 2.38 | 7.55 | 5.85 | ||
| Change | +0.01 | -0.53 | +0.53 | ||
| % Change | +0.42% | -6.56% | +9.96% | ||
| Volume | 43,600 | 115,021 | 48,764 | ||
| 20-Day Average Volume | 165,795 | 189,446 | 14,661 | ||
| Previous Close | 2.37 | 8.08 | 5.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.67 | 6.07 | 5.24 | ||
| 20-Day Raw Stochastic | 13.79% | 67.09% | 58.14% | ||
| 20-Day Relative Strength | 41.89% | 54.57% | 50.63% | ||
| Weighted Alpha | -64.70 | -68.64 | -42.21 | ||
| Today's Opinion | 88% Sell | 56% Sell | 32% Sell | ||
| Previous Opinion | 88% Sell | 56% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Sell | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.46% since 04/25/22 | +17.20% since 04/21/25 | +12.50% since 04/21/25 | ||
| Low | 2.22 on 04/27/22 | 6.26 on 04/22/25 | 5.03 on 04/22/25 | ||
| High | 2.56 on 04/29/22 | 8.73 on 04/25/25 | 6.66 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -22.98% since 04/01/22 | +33.76% since 03/28/25 | -7.99% since 03/28/25 | ||
| Low | 2.22 on 04/27/22 | 4.64 on 04/07/25 | 4.51 on 04/07/25 | ||
| High | 3.38 on 04/18/22 | 8.73 on 04/25/25 | 6.66 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -14.39% since 02/02/22 | -25.27% since 01/28/25 | -26.90% since 01/28/25 | ||
| Low | 2.07 on 03/14/22 | 4.64 on 04/07/25 | 4.51 on 04/07/25 | ||
| High | 3.38 on 04/18/22 | 11.58 on 02/06/25 | 8.86 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | -56.33% since 11/02/21 | -54.81% since 10/28/24 | -8.57% since 10/28/24 | ||
| Low | 2.07 on 03/14/22 | 4.64 on 04/07/25 | 3.72 on 12/27/24 | ||
| High | 5.57 on 11/04/21 | 20.77 on 11/07/24 | 11.78 on 01/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 61,047 | 61,405 | 59,972 | ||
| Shares Outstanding, K | 25,650 | 12,232 | 11,106 | ||
| Annual Sales | 2,110,000 | 0 | 2,090,000 | ||
| Annual Net Income | -35,070,000 | -40,210,000 | -5,490,000 | ||
| Last Quarter Sales | 610,000 | 0 | 650,000 | ||
| Last Quarter Net Income | -13,560,000 | -9,530,000 | -1,360,000 | ||
| 60-Month Beta | 0.45 | 3.12 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 03/14/22 | -0.78 on 03/11/25 | -0.12 on 12/03/24 | ||
| Latest Earnings Date | 05/04/22 | 05/06/25 | 04/29/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||